Skip to main content

Advertisement

SpringerLink
Log in

The role of LINE-1 methylation in predicting survival among colorectal cancer patients: a meta-analysis

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

The prognostic value of long interspersed nucleotide element-1 (LINE-1) methylation in patients with colorectal cancer (CRC) remains uncertain. We have therefore performed a meta-analysis to elucidate this issue.

Methods

The PubMed and Web of Science databases were searched for studies published up to 30 June 2016 which reported on an association between LINE-1 methylation and overall survival (OS), disease-free survival (DFS), or cancer-specific survival (CSS) among CRC patients. The reference lists of the identified studies were also analyzed to identify additional eligible studies. Hazard ratios (HRs) with 95% confidence intervals (CIs) were pooled using the fixed-effects or the random-effects model. Stratification analysis and meta-regression analysis were performed to detect the source of heterogeneity. Analyses of sensitivity and publication bias were also carried out.

Results

Thirteen independent studies involving 3620 CRC patients were recruited to the meta-analysis. LINE-1 hypomethylation was found to be significantly associated with shorter OS (HR 2.92, 95% CI 2.20–3.88, p < 0.001) and DFS (HR 2.18, 95% CI 1.46–3.27, p < 0.001), as well as unfavorable CSS (HR 1.96, 95% CI 1.35–2.85, p < 0.001). No heterogeneity was found among the studies evaluating the associations between LINE-1 hypomethylation and OS or DFS, with the exception being CSS. Moreover, meta-regression analysis suggested that one of the contributors to between-study heterogeneity on the association between LINE-1 methylation and CSS was statistical methodology. The subgroup analysis suggested that the association in studies using the Cox model statistical method (HR 2.76, 95% CI 1.90–4.01, p < 0.001) was stronger than that in studies using the Log-rank test (HR 1.41, 95% CI 1.07–1.87, p = 0.015).

Conclusions

The results of this meta-analysis suggest that LINE-1 methylation is significantly associated with the survival of CRC patients and that it could be a predictive factor for CRC prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Lavie L, Maldener E, Brouha B et al (2004) The human L1 promoter: variable transcription initiation sites and a major impact of upstream flanking sequence on promoter activity. Genome Res 14(11):2253–2260. doi:10.1101/gr.2745804

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Brouha B, Schustak J, Badge RM et al (2003) Hot L1s account for the bulk of retrotransposition in the human population. Proc Natl Acad Sci USA 100(9):5280–5285. doi:10.1073/pnas.0831042100

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Sassaman DM, Dombroski BA, Moran JV et al (1997) Many human L1 elements are capable of retrotransposition. Nat Genet 16(1):37–43. doi:10.1038/Ng0597-37

    Article  CAS  PubMed  Google Scholar 

  4. Steinhoff C, Schulz WA (2004) Transcriptional regulation of the human LINE-1 retrotransposon L1.2B. Mol Genet Genomics 270(5):394–402. doi:10.1007/s00438-003-0931-2

    Article  Google Scholar 

  5. Meissner A (2010) Epigenetic modifications in pluripotent and differentiated cells. Nat Biotechnol 28(10):1079–1088. doi:10.1038/nbt1684

    Article  CAS  PubMed  Google Scholar 

  6. Barlow DP (2011) Genomic imprinting: a mammalian epigenetic discovery model. Annu Rev Genet 45:379–403. doi:10.1146/annurev-genet-110410-132459

    Article  CAS  PubMed  Google Scholar 

  7. Martin M, Herceg Z (2012) From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms. Genome Med 4:8. doi:10.1186/gm307

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Baylin SB, Jones PA (2011) A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer 11(10):726–734. doi:10.1038/nrc3130

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Feinberg AP (2007) Phenotypic plasticity and the epigenetics of human disease. Nature 447(7143):433–440. doi:10.1038/nature05919

    Article  CAS  PubMed  Google Scholar 

  10. Yang AS, Estecio MRH, Doshi K et al (2004) A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 32(3):e38. doi:10.1093/nar/gnh032

    Article  PubMed  PubMed Central  Google Scholar 

  11. Harada K, Baba Y, Ishimoto T et al (2015) LINE-1 methylation level and patient prognosis in a database of 208 hepatocellular carcinomas. Ann Surg Oncol 22(4):1280–1287. doi:10.1245/s10434-014-4134-3

    Article  PubMed  Google Scholar 

  12. Ikeda K, Shiraishi K, Eguchi A et al (2013) Long interspersed nucleotide element 1 hypomethylation is associated with poor prognosis of lung adenocarcinoma. Ann Thorac Surg 96(5):1790–1795. doi:10.1016/j.athoracsur.2013.06.035

    Article  PubMed  Google Scholar 

  13. Cash HL, Tao L, Yuan JM et al (2012) LINE-1 hypomethylation is associated with bladder cancer risk among nonsmoking Chinese. Int J Cancer 130(5):1151–1159. doi:10.1002/ijc.26098

    Article  CAS  PubMed  Google Scholar 

  14. Baba Y, Huttenhower C, Nosho K et al (2010) Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors. Mol Cancer 9:125. doi:10.1186/1476-4598-9-125

    Article  PubMed  PubMed Central  Google Scholar 

  15. Tang JT, Wang ZH, Fang JY (2015) Assessing the potential value of long interspersed element-1 hypomethylation in colorectal cancer: evidence from retrospective studies. Oncotargets Ther 8:3265–3276. doi:10.2147/Ott.S91941

    Article  Google Scholar 

  16. Gallois C, Laurent-Puig P, Taieb J (2016) Methylator phenotype in colorectal cancer: a prognostic factor or not? Crit Rev Oncol Hemat 99:74–80. doi:10.1016/j.critrevonc.2015.11.001

    Article  CAS  Google Scholar 

  17. Ogino S, Nosho K, Kirkner GJ (2008) A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer. J Natl Cancer Inst 100(23):1734–1738. doi:10.1093/jnci/djn359

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62(10):e1–e34. doi:10.1016/j.jclinepi.2009.06.006

    Article  PubMed  Google Scholar 

  19. McShane LM, Altman DG, Sauerbrei W (2005) REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer 93(4):387–391. doi:10.1038/sj.bjc.6602678

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Tierney JF, Stewart LA, Ghersi D (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8:16. doi:10.1186/1745-6215-8-16

    Article  PubMed  PubMed Central  Google Scholar 

  21. Altman DG, Bland JM (2011) How to obtain the confidence interval from a P value. BMJ 343:d2090. doi:10.1136/bmj.d2090

    Article  PubMed  Google Scholar 

  22. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558. doi:10.1002/sim.1186

    Article  PubMed  Google Scholar 

  23. Higgins JP, Thompson SG, Deeks JJ et al (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560. doi:10.1136/bmj.327.7414.557

    Article  PubMed  PubMed Central  Google Scholar 

  24. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188

    Article  CAS  PubMed  Google Scholar 

  25. Greenland S (1987) Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 9:1–30

    Article  CAS  PubMed  Google Scholar 

  26. Hayashino Y, Noguchi Y, Fukui T (2005) Systematic evaluation and comparison of statistical tests for publication bias. J Epidemiol 15(6):235–243

    Article  PubMed  Google Scholar 

  27. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088–1101

    Article  CAS  PubMed  Google Scholar 

  28. Ahn JB, Chung WB, Maeda O et al (2011) DNA methylation predicts recurrence from resected stage III proximal colon cancer. Cancer 117(9):1847–1854. doi:10.1002/cncr.25737

    Article  CAS  PubMed  Google Scholar 

  29. Antelo M, Balaguer F, Shia J et al (2012) A high degree of LINE-1 hypomethylation is a unique feature of early-onset colorectal cancer. PLoS One 7(9):e45357. doi:10.1371/journal.pone.0045357

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Benard A, van de Velde CJH, Lessard L et al (2013) Epigenetic status of LINE-1 predicts clinical outcome in early-stage rectal cancer. Br J Cancer 109(12):3073–3083. doi:10.1038/bjc.2013.654

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Chen D, Wen X, Song YS et al (2016) Associations and prognostic implications of Eastern Cooperative Oncology Group performance status and tumoral LINE-1 methylation status in stage III colon cancer patients. Clin Epigenetics 8:36. doi:10.1186/s13148-016-0203-8

    Article  PubMed  PubMed Central  Google Scholar 

  32. Kawakami K, Matsunoki A, Kaneko M et al (2011) Long interspersed nuclear element-1 hypomethylation is a potential biomarker for the prediction of response to oral fluoropyrimidines in microsatellite stable and CpG island methylator phenotype-negative colorectal cancer. Cancer Sci 102(1):166–174. doi:10.1111/j.1349-7006.2010.01776.x

    Article  CAS  PubMed  Google Scholar 

  33. Lou YT, Chen CW, Fan YC et al (2015) LINE-1 methylation status correlates significantly to post-therapeutic recurrence in stage III colon cancer patients receiving FOLFOX-4 adjuvant chemotherapy. PLoS One 10(4):1011. doi:10.1371/journal.pone.0123973

    Article  Google Scholar 

  34. Mima K, Nowak JA, Qian ZR et al (2016) Tumor LINE-1 methylation level and colorectal cancer location in relation to patient survival. Oncotarget. doi:10.18632/oncotarget.10398

    Google Scholar 

  35. Murata A, Baba Y, Watanabe M et al (2013) Methylation levels of LINE-1 in primary lesion and matched metastatic lesions of colorectal cancer. Br J Cancer 109(2):408–415. doi:10.1038/bjc.2013.289

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Naito T, Nosho K, Ito M et al (2014) IGF2 differentially methylated region hypomethylation in relation to pathological and molecular features of serrated lesions. World J Gastroentero 20(29):10050–10061. doi:10.3748/wjg.v20.i29.10050

    Article  CAS  Google Scholar 

  37. Rhee YY, Kim MJ, Bae JM et al (2012) Clinical outcomes of patients with microsatellite-unstable colorectal carcinomas depend on L1 methylation level. Ann Surg Oncol 19(11):3441–3448. doi:10.1245/s10434-012-2410-7

    Article  PubMed  Google Scholar 

  38. Sahnane N, Magnoli F, Bernasconi B et al (2015) Aberrant DNA methylation profiles of inherited and sporadic colorectal cancer. Clin Epigenetics 7:131. doi:10.1186/s13148-015-0165-2

    Article  PubMed  PubMed Central  Google Scholar 

  39. Zhuo CH, Li QG, Wu YC et al (2015) LINE-1 hypomethylation in normal colon mucosa is associated with poor survival in Chinese patients with sporadic colon cancer. Oncotarget 6(27):23820–23836. doi:10.18632/oncotarget.4450

    Article  PubMed  PubMed Central  Google Scholar 

  40. Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386. doi:10.1002/ijc.29210

    Article  CAS  PubMed  Google Scholar 

  41. Grade M, Becker H, Liersch T et al (2006) Molecular cytogenetics: genomic imbalances in colorectal cancer and their clinical impact. Cell Oncol 28(3):71–84

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Levin B, Lieberman DA, McFarland B et al (2008) Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 134(5):1570–1595. doi:10.1053/j.gastro.2008.02.002

    Article  CAS  PubMed  Google Scholar 

  43. Juo YY, Johnston FM, Zhang DY et al (2014) Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis. Ann Oncol 25(12):2314–2327. doi:10.1093/annonc/mdu149

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Jiang W, Wang PG, Zhan Y et al (2014) Prognostic value of p16 promoter hypermethylation in colorectal cancer: a meta-analysis. Cancer Invest 32(2):43–52. doi:10.3109/07357907.2013.861476

    Article  CAS  PubMed  Google Scholar 

  45. Xing X, Cai W, Shi H et al (2013) The prognostic value of CDKN2A hypermethylation in colorectal cancer: a meta-analysis. Br J Cancer 108(12):2542–2548. doi:10.1038/bjc.2013.251

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Li Y, Lyu Z, Zhao L et al (2015) Prognostic value of MGMT methylation in colorectal cancer: a meta-analysis and literature review. Tumour Biol 36(3):1595–1601. doi:10.1007/s13277-014-2752-9

    Article  PubMed  Google Scholar 

  47. Estecio MRH, Gharibyan V, Shen LL et al (2007) LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability. PLoS One 2(5):e399. doi:10.1371/journal.pone.0000399

    Article  PubMed  PubMed Central  Google Scholar 

  48. Ogino S, Kawasaki T, Nosho K et al (2008) LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer. Int J Cancer 122(12):2767–2773. doi:10.1002/ijc.23470

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Epidemiology and Health Statistics, Zhejiang University School of Public Health, 866 Yuhangtang Road, Hangzhou, 310058, China

    Ding Ye, Danjie Jiang, Mingjuan Jin & Kun Chen

  2. Department of Public Health, Hangzhou Medical School, Hangzhou, China

    Yingjun Li

Authors
  1. Ding Ye
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Danjie Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yingjun Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mingjuan Jin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kun Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kun Chen.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Funding

This study was funded by the National Key Basic Research Program (973 Program No. 2015CB554003).

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PPTX 29 kb)

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ye, D., Jiang, D., Li, Y. et al. The role of LINE-1 methylation in predicting survival among colorectal cancer patients: a meta-analysis. Int J Clin Oncol 22, 749–757 (2017). https://doi.org/10.1007/s10147-017-1106-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-017-1106-1

Keywords

Search

Navigation